NASDAQ : CHRS
Coherus Oncology, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 0.8301 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 128.25M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Coherus Oncology, Inc. (CHRS) reported revenue of 50.94M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Operating Revenue | 50.94M | 42.17M | 26.39M | 257.24M | 211.04M | 326.55M |
| Revenue | 50.94M | 42.17M | 26.39M | 257.24M | 211.04M | 326.55M |
| Cost of Revenue | 15.81M | 13.81M | 8.73M | 158.99M | 70.08M | 57.59M |
| Gross Profit | 35.12M | 28.36M | 17.66M | 98.25M | 140.96M | 268.96M |
| Selling, General & Admin | 87.90M | 95.90M | 114.88M | 185.62M | 198.48M | 169.71M |
| Research & Development | 101.22M | 108.89M | 91.83M | 105.84M | 199.36M | 363.11M |
| Operating Expenses | 189.12M | 204.79M | 206.72M | 291.45M | 397.84M | 532.82M |
| Operating Income | -154.00M | -176.43M | -189.05M | -193.20M | -256.88M | -263.86M |
| Interest Expense | -9.08M | -9.00M | -10.73M | -40.54M | -32.47M | -22.96M |
| Interest & Investment Income | 7.00M | 7.00M | 4.50M | 2.80M | 1.90M | 1.40M |
| Other Non Operating Income (Expenses) | -368.00K | 11.00K | 3.12M | 2.67M | 1.92M | -1.68M |
| EBT Excluding Unusual Items | -156.45M | -178.42M | -192.16M | -228.27M | -285.53M | -287.10M |
| Merger & Restructuring Charges | -10.00M | |||||
| Asset Writedown | -4.70M | -4.70M | -10.60M | |||
| Other Unusual Items | -12.63M | -6.22M | ||||
| Pretax Income | -161.15M | -183.12M | -215.39M | -238.27M | -291.75M | -287.10M |
| Income Tax Expense | -380.00K | |||||
| Earnings From Continuing Operations | -161.15M | -183.12M | -215.39M | -237.89M | -291.75M | -287.10M |
| Earnings From Discontinued Operations | 29.01M | 351.15M | 243.90M | |||
| Net Income to Company | -132.13M | 168.02M | 28.51M | -237.89M | -291.75M | -287.10M |
| Net Income | -132.13M | 168.02M | 28.51M | -237.89M | -291.75M | -287.10M |
| Net Income to Common | -132.13M | 168.02M | 28.51M | -237.89M | -291.75M | -287.10M |
| Shares Outstanding (Basic) | 131.99M | 117.14M | 114.55M | 94.16M | 77.63M | 75.45M |
| Shares Outstanding (Diluted) | 131.99M | 117.14M | 114.55M | 94.16M | 77.63M | 75.45M |
| EPS (Basic) | -1.00 | 1.43 | 0.25 | -2.53 | -3.76 | -3.81 |
| EPS (Diluted) | -1.00 | 1.43 | 0.25 | -2.53 | -3.76 | -3.81 |
| Free Cash Flow | -186.03M | -138.51M | -20.44M | -174.88M | -241.12M | -38.72M |
| Free Cash Flow Per Share | -1.41 | -1.18 | -0.18 | -1.86 | -3.11 | -0.51 |
| Gross Margin | 68.95% | 67.24% | 66.93% | 38.19% | 66.79% | 82.36% |
| Operating Margin | -302.33% | -418.37% | -716.41% | -75.10% | -121.72% | -80.80% |
| Profit Margin | -259.41% | 398.43% | 108.03% | -92.48% | -138.25% | -87.92% |
| Free Cash Flow Margin | -365.23% | -328.45% | -77.46% | -67.98% | -114.25% | -11.86% |
| EBITDA | -150.39M | -172.51M | -183.78M | -189.41M | -253.18M | -260.40M |
| EBITDA Margin | -295.25% | -73.63% | -119.97% | -79.74% | ||
| D&A For EBITDA | 3.60M | 3.92M | 5.28M | 3.79M | 3.70M | 3.45M |
| EBIT | -154.00M | -176.43M | -189.05M | -193.20M | -256.88M | -263.86M |
| EBIT Margin | -75.10% | -121.72% | -80.80% | |||
| Advertising Expenses | 6.60M | 7.40M | 10.90M | 10.50M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 82.92M | 88.88M | 125.99M | 102.89M | 63.55M | 417.19M |
| Short-Term Investments | 22.38M | 83.25M | 14.86M | 128.13M | ||
| Cash & Short-Term Investments | 105.31M | 172.12M | 125.99M | 117.75M | 191.68M | 417.19M |
| Accounts Receivable | 13.88M | 17.82M | 111.32M | 260.52M | 109.96M | 123.02M |
| Other Receivables | 372.00K | 603.00K | 11.01M | |||
| Receivables | 14.25M | 18.42M | 122.33M | 260.52M | 109.96M | 123.02M |
| Inventory | 5.67M | 3.17M | 4.21M | 62.60M | 38.79M | 37.64M |
| Prepaid Expenses | 8.56M | 12.99M | 16.88M | 34.76M | 40.80M | 24.46M |
| Other Current Assets | 72.18M | |||||
| Total Current Assets | 133.79M | 206.71M | 341.58M | 475.63M | 381.23M | 602.32M |
| Property, Plant & Equipment | 865.00K | 4.30M | 7.09M | 11.03M | 14.44M | 16.01M |
| Goodwill | 943.00K | 943.00K | 900.00K | |||
| Other Intangible Assets | 44.99M | 46.24M | 53.65M | 70.73M | 4.99M | 2.66M |
| Other Long-Term Assets | 11.54M | 1.10M | 46.21M | 71.27M | 79.24M | 57.44M |
| Total Assets | 191.18M | 258.34M | 448.53M | 629.60M | 480.85M | 679.33M |
| Accounts Payable | 13.17M | 9.91M | 28.46M | 35.22M | 11.53M | 16.16M |
| Accrued Expenses | 37.73M | 63.58M | 227.04M | 291.11M | 122.85M | 145.68M |
| Current Portion of Long-Term Debt | 1.15M | |||||
| Current Portion of Leases | 1.95M | 1.83M | 1.69M | 2.15M | 4.32M | 3.49M |
| Other Current Liabilities | 22.66M | 65.06M | 24.65M | 3.30M | ||
| Total Current Liabilities | 75.51M | 140.39M | 282.98M | 331.77M | 138.69M | 165.33M |
| Long-Term Debt | 51.77M | 51.08M | 292.52M | 473.37M | 471.06M | 408.28M |
| Long-Term Leases | 459.00K | 1.46M | 3.29M | 5.33M | 5.05M | 7.25M |
| Long-Term Deferred Tax Liabilities | 1.10M | 1.10M | 1.10M | 1.10M | ||
| Other Long-Term Liabilities | 1.50M | 3.31M | 632.00K | 11.46M | 3.47M | 750.00K |
| Total Liabilities | 130.34M | 197.33M | 580.52M | 823.03M | 618.26M | 581.61M |
| Common Stock | 15.00K | 12.00K | 12.00K | 11.00K | 8.00K | 7.00K |
| Additional Paid-In Capital | 1.50B | 1.44B | 1.42B | 1.39B | 1.20B | 1.15B |
| Retained Earnings | -1.44B | -1.38B | -1.55B | -1.58B | -1.34B | -1.05B |
| Comprehensive Income & Other | -281.00K | -195.00K | -275.00K | -248.00K | -249.00K | -270.00K |
| Total Common Equity | 60.84M | 61.01M | -131.99M | -193.43M | -137.42M | 97.73M |
| Shareholders' Equity | 60.84M | 61.01M | -131.99M | -193.43M | -137.42M | 97.73M |
| Total Liabilities & Equity | 191.18M | 258.34M | 448.53M | 629.60M | 480.85M | 679.33M |
| Total Debt | 54.18M | 54.36M | 298.65M | 480.84M | 480.42M | 419.02M |
| Net Cash (Debt) | 51.13M | 117.76M | -172.66M | -363.09M | -288.74M | -1.83M |
| Net Cash Per Share | 0.39 | 1.01 | -1.51 | -3.86 | -3.72 | -0.02 |
| Filing Date Shares Outstanding | 154.50M | 149.89M | 115.90M | 112.71M | 79.61M | 77.28M |
| Total Common Shares Outstanding | 154.47M | 121.15M | 115.61M | 112.22M | 78.85M | 76.93M |
| Working Capital | 58.28M | 66.32M | 58.60M | 143.86M | 242.54M | 437.00M |
| Book Value Per Share | 0.39 | 0.50 | -1.14 | -1.72 | -1.74 | 1.27 |
| Tangible Book Value | 15.85M | 14.78M | -185.64M | -265.10M | -143.35M | 94.16M |
| Tangible Book Value Per Share | 0.10 | 0.12 | -1.61 | -2.36 | -1.82 | 1.22 |
| Machinery | 10.81M | 18.07M | 17.73M | 17.39M | 16.04M | |
| Construction In Progress | 696.00K | 388.00K | ||||
| Leasehold Improvements | 5.76M | 5.75M | 5.75M | 6.20M | 5.94M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -132.13M | 168.02M | 28.51M | -237.89M | -291.75M | -287.10M |
| Depreciation & Amortization | 3.60M | 3.92M | 5.28M | 3.79M | 3.70M | 3.45M |
| Other Amortization | 2.41M | 6.43M | 4.26M | |||
| Loss (Gain) From Sale of Assets | -338.31M | -338.31M | -176.59M | |||
| Asset Writedown & Restructuring Costs | 4.66M | 4.66M | 10.57M | 3.21M | ||
| Loss (Gain) From Sale of Investments | 1.09M | |||||
| Stock-Based Compensation | 11.14M | 16.97M | 27.80M | 43.11M | 50.74M | 51.36M |
| Other Operating Activities | -25.35M | 12.07M | 28.10M | 50.53M | 69.02M | 143.93M |
| Change in Accounts Receivable | -8.66M | 93.56M | 149.35M | -150.68M | 13.05M | 34.06M |
| Change in Inventory | -9.51M | -17.11M | -31.95M | -46.73M | -47.35M | -6.25M |
| Change in Accounts Payable | -16.14M | -19.56M | -3.94M | 23.76M | -4.55M | 874.00K |
| Change in Other Net Operating Assets | -15.14M | -62.73M | -57.57M | 136.83M | -40.41M | 13.68M |
| Operating Cash Flow | -186.03M | -138.51M | -20.44M | -174.88M | -241.12M | -37.43M |
| Capital Expenditures | -1.29M | |||||
| Cash Acquisitions | 7.00M | |||||
| Sale (Purchase) of Intangibles | -12.50M | -12.50M | -35.00M | |||
| Investment in Securities | -264.00K | -82.38M | 14.89M | 138.13M | -127.38M | -1.12M |
| Other Investing Activities | -9.52M | 469.96M | 227.93M | -492.00K | -4.47M | -136.00M |
| Investing Cash Flow | -9.78M | 375.09M | 230.32M | 144.64M | -166.85M | -138.41M |
| Long-Term Debt Issued | 36.98M | 240.68M | ||||
| Long-Term Debt Repaid | -233.19M | -260.39M | -190.75M | |||
| Net Debt Issued (Repaid) | -121.00K | -233.19M | -223.41M | 49.93M | ||
| Issuance of Common Stock | 61.91M | 8.25M | 2.38M | 74.22M | 9.37M | 54.30M |
| Repurchase of Common Stock | -115.00K | -283.00K | -2.48M | -3.59M | -3.74M | -1.75M |
| Other Financing Activities | 142.00K | -48.48M | 36.53M | -1.03M | -1.23M | -672.00K |
| Financing Cash Flow | 61.82M | -273.70M | -186.97M | 69.60M | 54.33M | 51.88M |
| Net Cash Flow | -133.99M | -37.13M | 22.91M | 39.36M | -353.65M | -123.96M |
| Free Cash Flow | -186.03M | -138.51M | -20.44M | -174.88M | -241.12M | -38.72M |
| Free Cash Flow Margin | -365.23% | -328.45% | -77.46% | -67.98% | -114.25% | -11.86% |
| Free Cash Flow Per Share | -1.41 | -1.18 | -0.18 | -1.86 | -3.11 | -0.51 |
| Levered Free Cash Flow | -160.15M | -68.72M | -13.17M | -69.86M | -186.86M | -60.97M |
| Unlevered Free Cash Flow | -154.47M | -63.10M | -6.46M | -46.93M | -173.00M | -50.88M |
| Cash Interest Paid | 9.92M | 9.92M | 25.38M | 37.86M | 34.88M | 18.68M |
| Cash Income Tax Paid | 36.00K | 36.00K | -114.00K | -118.00K | 40.00K | 1.22M |
| Change in Working Capital | -49.45M | -5.84M | 55.89M | -36.83M | -79.26M | 42.36M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 117.47M | 171.64M | 158.99M | 370.84M | 777.58M | 1.23B |
| Enterprise Value | 66.34M | 34.29M | 360.79M | 718.44M | 971.49M | 1.18B |
| Last Close Price | 0.83 | 1.42 | 1.38 | 3.33 | 7.92 | 15.96 |
| PE Ratio | 1.02 | 5.58 | ||||
| Forward PE | 138.29 | 23.31 | 23.31 | 23.31 | 23.31 | |
| PS Ratio | 2.52 | 4.07 | 6.03 | 1.44 | 3.68 | 3.75 |
| PB Ratio | 2.11 | 2.81 | -1.21 | -1.92 | -5.66 | 12.54 |
| P/TBV Ratio | 8.09 | 11.62 | 13.02 | |||
| PEG Ratio | 62.23 | 62.23 | 62.23 | 62.23 | 62.23 | |
| EV/Sales Ratio | 1.51 | 0.81 | 13.67 | 2.79 | 4.60 | 3.60 |
| Debt / Equity Ratio | 0.89 | 0.89 | -2.26 | -2.49 | -3.50 | 4.29 |
| Net Debt / Equity Ratio | -0.84 | -1.93 | -1.31 | -1.88 | -2.10 | 0.02 |
| Net Debt / EBITDA Ratio | 0.34 | 0.68 | -0.94 | -1.92 | -1.14 | -0.01 |
| Net Debt / FCF Ratio | 0.28 | 0.85 | -8.45 | -2.08 | -1.20 | -0.05 |
| Asset Turnover | 0.16 | 0.12 | 0.05 | 0.46 | 0.36 | 0.43 |
| Inventory Turnover | 3.11 | 3.74 | 0.26 | 3.14 | 1.83 | 1.41 |
| Quick Ratio | 1.58 | 1.36 | 0.88 | 1.14 | 2.17 | 3.27 |
| Current Ratio | 1.77 | 1.47 | 1.21 | 1.43 | 2.75 | 3.64 |
| Return on Equity (ROE) | -178.39% | -151.62% | ||||
| Return on Assets (ROA) | -30.52% | -31.20% | -21.92% | -21.75% | -27.68% | -21.68% |
| Return on Invested Capital (ROIC) | -1,586.11% | -81.60% | -60.38% | -116.31% | -205.76% | |
| Return on Capital Employed (ROCE) | -133.10% | -149.60% | -114.20% | -64.90% | -75.10% | -51.30% |
| Earnings Yield | -131.67% | 97.89% | 17.93% | -64.15% | -37.52% | -23.43% |
| FCF Yield | -145.05% | -80.70% | -12.86% | -47.16% | -31.01% | -3.16% |
| Buyback Yield / Dilution | -14.13% | -2.26% | -21.65% | -21.30% | -2.89% | 9.63% |